PROCEPT BioRobotics® to Report Second Quarter 2025 Financial Results on August 6, 2025
PROCEPT BioRobotics (Nasdaq: PRCT), a surgical robotics company specializing in urological solutions, has scheduled its Q2 2025 financial results announcement for August 6, 2025 after market close.
The company will host a conference call at 4:30 p.m. Eastern Time to discuss the results. Investors can access the call through a webcast link or dial-in registration for sell-side analysts. The webcast recording will be available for at least 90 days on the company's investor relations website.
PROCEPT BioRobotics (Nasdaq: PRCT), azienda specializzata in soluzioni urologiche nel campo della robotica chirurgica, ha programmato l'annuncio dei risultati finanziari del secondo trimestre 2025 per il 6 agosto 2025 dopo la chiusura dei mercati.
L'azienda terrà una conference call alle 16:30 ora della costa orientale per discutere i risultati. Gli investitori potranno partecipare alla chiamata tramite un link webcast o registrandosi per la chiamata telefonica riservata agli analisti sell-side. La registrazione del webcast sarà disponibile per almeno 90 giorni sul sito web delle relazioni con gli investitori dell'azienda.
PROCEPT BioRobotics (Nasdaq: PRCT), una empresa de robótica quirúrgica especializada en soluciones urológicas, ha programado el anuncio de resultados financieros del segundo trimestre de 2025 para el 6 de agosto de 2025 después del cierre del mercado.
La compañía realizará una llamada conferencia a las 4:30 p.m. hora del Este para discutir los resultados. Los inversores podrán acceder a la llamada a través de un enlace de webcast o mediante registro para llamada telefónica destinada a analistas sell-side. La grabación del webcast estará disponible durante al menos 90 días en la página web de relaciones con inversores de la compañía.
PROCEPT BioRobotics (나스닥: PRCT)는 비뇨기과 솔루션에 특화된 수술용 로봇 회사로, 2025년 8월 6일 장 마감 이후에 2025년 2분기 재무 실적 발표를 예정하고 있습니다.
회사는 동부 표준시 오후 4시 30분에 실적에 대해 논의하기 위한 컨퍼런스 콜을 개최할 예정입니다. 투자자들은 웹캐스트 링크를 통해 접속하거나 셀사이드 애널리스트를 위한 전화 등록을 통해 참여할 수 있습니다. 웹캐스트 녹화본은 회사 투자자 관계 웹사이트에서 최소 90일간 제공됩니다.
PROCEPT BioRobotics (Nasdaq : PRCT), une entreprise de robotique chirurgicale spécialisée dans les solutions urologiques, a prévu l'annonce des résultats financiers du deuxième trimestre 2025 pour le 6 août 2025 après la clôture du marché.
La société organisera une conférence téléphonique à 16h30, heure de l'Est pour discuter des résultats. Les investisseurs pourront accéder à l'appel via un lien webcast ou s'inscrire pour une participation téléphonique réservée aux analystes sell-side. L'enregistrement du webcast sera disponible pendant au moins 90 jours sur le site des relations investisseurs de l'entreprise.
PROCEPT BioRobotics (Nasdaq: PRCT), ein auf urologische Lösungen spezialisiertes Unternehmen für chirurgische Robotik, hat die Veröffentlichung der Finanzergebnisse für das zweite Quartal 2025 für den 6. August 2025 nach Börsenschluss geplant.
Das Unternehmen wird um 16:30 Uhr Eastern Time eine Telefonkonferenz abhalten, um die Ergebnisse zu besprechen. Investoren können über einen Webcast-Link teilnehmen oder sich für die Telefonkonferenz für Sell-Side-Analysten registrieren. Die Aufzeichnung des Webcasts wird mindestens 90 Tage auf der Investor-Relations-Website des Unternehmens verfügbar sein.
- None.
- None.
SAN JOSE, Calif., July 21, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced it will report financial results for the second quarter of 2025 after market close on Wednesday, August 6, 2025. The Company’s management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time.
Investors interested in listening to the conference call may do so by following one of the below links:
- Webcast link for interested listeners:
- Dial-in registration for sell-side research analysts:
Live audio of the webcast will be available on the “Investors” section of the Company’s website at: https://ir.procept-biorobotics.com.
An archived recording will be available on the “Investors” section of the Company’s website at: https://ir.procept-biorobotics.com. Each webcast will be available for replay for at least 90 days after the event.
About PROCEPT BioRobotics Corporation
PROCEPT BioRobotics’ mission is to revolutionize BPH treatment globally in partnership with urologists by delivering best-in-class robotic solutions that positively impact patients and drive value. PROCEPT BioRobotics manufactures the AQUABEAM® and HYDROS™ Robotic Systems. The HYDROS Robotic System is the only AI-Powered, robotic technology that delivers Aquablation therapy. PROCEPT BioRobotics designed Aquablation therapy to deliver effective, safe, and durable outcomes for males suffering from lower urinary tract symptoms or LUTS, due to BPH that are independent of prostate size and shape or surgeon experience. BPH is the most common prostate disease and impacts approximately 40 million men in the United States. The Company has developed a significant and growing body of clinical evidence with over 150 peer-reviewed publications, supporting the benefits and clinical advantages of Aquablation therapy.
Investor Contact:
Matt Bacso
VP, Investor Relations and Business Operations
m.bacso@PROCEPT-BioRobotics.com
FAQ
When will PROCEPT BioRobotics (PRCT) report Q2 2025 earnings?
What time is PROCEPT BioRobotics' Q2 2025 earnings call?
How can investors access PROCEPT BioRobotics' Q2 2025 earnings call?
How long will PROCEPT BioRobotics' Q2 2025 earnings call recording be available?
